GL1X · GenesisL1 explorer

MolNFT v1 · #27905 · protein

Structural insights for fatty acid binding in a LYS49 phospholipase A2: crystal structure of myotoxin II from bothrops moojeni complexed with stearic acid

1XXS · Phospholipase A2 homolog 2: “Structural insights for fatty acid binding in a LYS49 phospholipase A2: crystal structure of myotoxin II from…”. X-ray diffraction, 2 ligands (STE, SO4), 3 pockets (best druggability 0.56). MolNFT v1…

PDB
1XXS
Type
protein
Length
244 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phospholipase A2 homolog 2
EC
3.1.1.4
UniProt
Q9I834
Ligands
STE, SO4
Pockets
3 · best druggability 0.56

Structure

x-ray diffraction · 1 distinct chain · 48% helix, 8% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BPhospholipase A2 homolog 2 (EC 3.1.1.4)protein12248% helix, 8% strandQ9I834

Ligands and binding sites

  • STE · Stearic acid · ligand · 6 copies · chains A, B
  • SO4 · Sulfate ion · ion · 5 copies · chains B, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11090.560.8419STE
21300.480.7821STE
3900.380.7610STE

Interfaces

1 interface between chains.

  • A–B · 396 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 14 disulfide (disulfide).

Compared structures

  • 1XXS · Structural insights for fatty acid binding in a Lys49 phospholipase A2: crystal structure… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9I834 · AlphaFold monomer V2.0 prediction for basic phospholipase A2 homolog myotoxin II (Q9I834) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.